US Stock MarketDetailed Quotes

AbCellera Biologics (ABCL)

Watchlist
  • 4.225
  • +0.045+1.08%
Trading Jan 16 15:18 ET
1.26BMarket Cap-7.41P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AbCellera Biologics (ABCL) Revenue Breakdown Overview

By Business/Source

Currency:USD
2024/FY
Stock NameRevenueRatio
Discovery and development of antibody drugs28.83M100.00%

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
Canada26.2M90.66%
United States2.7M9.34%
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.04%
Sample Name
Sample Code
 +2.61%
Sample Name
Sample Code
 +2.45%
4
Tempus AI
TEM
+2.42%
5
Block
XYZ
+1.17%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.76%
Sample Name
Sample Code
 +10.29%
Sample Name
Sample Code
 +9.91%
4
Kingsoft Cloud
KC
+7.26%
5
United Microelectronics
UMC
+6.31%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -